• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA085902J
Device Problem Patient Device Interaction Problem (4001)
Event Date 02/20/2019
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2019, the patient underwent an endovascular treatment for a right internal iliac artery aneurysm using a gore® viabahn® vbx balloon expandable endoprosthesis.The gore® viabahn® vbx balloon expandable endoprosthesis was implanted to extend the internal iliac component to the right superior gluteal artery.The right inferior gluteal artery was embolized as planned.The type ii endoleak was observed after the device was implanted.Ballooning was performed again and the procedure was concluded without confirmation angiography.On an unknown date, ct imaging showed enlargement of the aneurysm.A type ii or iii endoleak was suspected.On (b)(6) 2023, a reintervention was performed.An intraoperative angiography confirmed the type ii endoleak.There was no type iii endoleak confirmed.In order to treat the type ii endoleak, a branch vessel from the right internal iliac artery and the right superior gluteal artery were embolized.A gore® viabahn® vbx balloon expandable endoprosthesis was implanted in the right internal iliac artery to the right superior gluteal artery to extend the previous implanted gore® viabahn® vbx balloon expandable endoprosthesis.
 
Manufacturer Narrative
A review of the manufacturing records indicated the device met pre-release specifications.Updated investigation findings: c19.Updated investigation conclusions: d15.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
jorja nackard
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16686483
MDR Text Key312759482
Report Number2017233-2023-03845
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/09/2021
Device Catalogue NumberBXA085902J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age63 YR
Patient SexMale
-
-